| Product Code: ETC9941699 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market - Industry Life Cycle |
3.4 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market - Porter's Five Forces |
3.5 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.7 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the UK |
4.2.2 Growing awareness about the benefits of continuous subcutaneous insulin infusion therapy |
4.2.3 Technological advancements in insulin delivery systems |
4.2.4 Favorable reimbursement policies for insulin pumps |
4.2.5 Rising adoption of personalized healthcare solutions |
4.3 Market Restraints |
4.3.1 High cost associated with continuous subcutaneous insulin infusion therapy |
4.3.2 Limited access to specialized healthcare professionals for managing insulin pumps |
4.3.3 Concerns regarding the reliability and accuracy of insulin pump technology |
4.3.4 Regulatory challenges and compliance issues in the UK healthcare system |
4.3.5 Resistance from traditional healthcare providers towards adopting new treatment methods |
5 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Trends |
6 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market, By Types |
6.1 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Tethered, 2021- 2031F |
6.1.4 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Patch, 2021- 2031F |
6.2 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market, By End Use |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 1 diabetes, 2021- 2031F |
6.3.3 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 2 diabetes, 2021- 2031F |
7 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Export to Major Countries |
7.2 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Imports from Major Countries |
8 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Key Performance Indicators |
8.1 Average HbA1c levels of diabetic patients using continuous subcutaneous insulin infusion therapy |
8.2 Rate of hospitalizations due to diabetic complications among patients using insulin pumps |
8.3 Patient satisfaction scores related to the usability and effectiveness of insulin pump devices |
8.4 Number of healthcare providers offering continuous subcutaneous insulin infusion therapy services |
8.5 Percentage of healthcare facilities equipped with necessary infrastructure for supporting insulin pump therapy |
9 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market - Opportunity Assessment |
9.1 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.3 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market - Competitive Landscape |
10.1 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Continuous Subcutaneous Insulin Infusion Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here